These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 9807647

  • 1. Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers.
    Rupprecht R, Ströhle A, Hermann B, di Michele F, Spalletta G, Pasini A, Holsboer F, Romeo E.
    Biol Psychiatry; 1998 Nov 01; 44(9):912-4. PubMed ID: 9807647
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of antidepressant treatment on neuroactive steroids in major depression.
    Romeo E, Ströhle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R.
    Am J Psychiatry; 1998 Jul 01; 155(7):910-3. PubMed ID: 9659856
    [Abstract] [Full Text] [Related]

  • 4. The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles.
    Raven PW, O'Dwyer AM, Taylor NF, Checkley SA.
    Psychoneuroendocrinology; 1996 Apr 01; 21(3):277-86. PubMed ID: 8817726
    [Abstract] [Full Text] [Related]

  • 5. Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone.
    Rupprecht R, Kornhuber J, Wodarz N, Lugauer J, Göbel C, Haack D, Beck G, Müller OA, Riederer P, Beckmann H.
    Biol Psychiatry; 1991 Jun 01; 29(11):1099-109. PubMed ID: 1651773
    [Abstract] [Full Text] [Related]

  • 6. Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status.
    Ur E, Dinan TG, O'Keane V, Clare AW, McLoughlin L, Rees LH, Turner TH, Grossman A, Besser GM.
    Neuroendocrinology; 1992 Oct 01; 56(4):533-8. PubMed ID: 1335555
    [Abstract] [Full Text] [Related]

  • 7. Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment.
    von Bardeleben U, Stalla GK, Müller OA, Holsboer F.
    Biol Psychiatry; 1988 Nov 01; 24(7):782-6. PubMed ID: 2852510
    [Abstract] [Full Text] [Related]

  • 8. Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy.
    Murphy BE, Ghadirian AM, Dhar V.
    Can J Psychiatry; 1998 Apr 01; 43(3):279-86. PubMed ID: 9561317
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients.
    Young EA, Haskett RF, Grunhaus L, Pande A, Weinberg VM, Watson SJ, Akil H.
    Arch Gen Psychiatry; 1994 Sep 01; 51(9):701-7. PubMed ID: 8080346
    [Abstract] [Full Text] [Related]

  • 11. Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression.
    Baghai TC, di Michele F, Schüle C, Eser D, Zwanzger P, Pasini A, Romeo E, Rupprecht R.
    Neuropsychopharmacology; 2005 Jun 01; 30(6):1181-6. PubMed ID: 15702138
    [Abstract] [Full Text] [Related]

  • 12. Extra-adrenal effects of metyrapone include inhibition of the 11-oxoreductase activity of 11 beta-hydroxysteroid dehydrogenase: a model for 11-HSD I deficiency.
    Raven PW, Checkley SA, Taylor NF.
    Clin Endocrinol (Oxf); 1995 Nov 01; 43(5):637-44. PubMed ID: 8548950
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sleep endocrine effects of the 11-beta-hydroxysteroiddehydrogenase inhibitor metyrapone.
    Jahn H, Kiefer F, Schick M, Yassouridis A, Steiger A, Kellner M, Wiedemann K.
    Sleep; 2003 Nov 01; 26(7):823-9. PubMed ID: 14655915
    [Abstract] [Full Text] [Related]

  • 16. Normal pituitary response to metyrapone in the morning in depressed patients: implications for circadian regulation of corticotropin-releasing hormone secretion.
    Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H.
    Biol Psychiatry; 1997 Jun 15; 41(12):1149-55. PubMed ID: 9171905
    [Abstract] [Full Text] [Related]

  • 17. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA, Akil H, Haskett RF, Watson SJ.
    Biol Psychiatry; 1995 Mar 15; 37(6):355-63. PubMed ID: 7772643
    [Abstract] [Full Text] [Related]

  • 18. Influence of sleep deprivation on neuroactive steroids in major depression.
    Schüle C, di Michele F, Baghai T, Romeo E, Bernardi G, Zwanzger P, Padberg F, Pasini A, Rupprecht R.
    Neuropsychopharmacology; 2003 Mar 15; 28(3):577-81. PubMed ID: 12629540
    [Abstract] [Full Text] [Related]

  • 19. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
    Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schüle C, Rupprecht R, Romeo E.
    Neuropsychopharmacology; 2005 Jan 15; 30(1):192-5. PubMed ID: 15467707
    [Abstract] [Full Text] [Related]

  • 20. Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression.
    Padberg F, di Michele F, Zwanzger P, Romeo E, Bernardi G, Schüle C, Baghai TC, Ella R, Pasini A, Rupprecht R.
    Neuropsychopharmacology; 2002 Nov 15; 27(5):874-8. PubMed ID: 12431862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.